Genome Canada Statement of financial position as at March 31, 2017 (in thousands of dollars) 2017 2016 $ $ Assets Current assets Cash and cash equivalents (Note 3) 21,637 32,736 Interest receivable 125 83 Other receivables 93 135 Prepaid expenses 154 158 22,009 33,112 Investments (Note 4) 27,808 11,863 Capital assets (Note 5) 100 118 49,917 45,093 Liabilities Current liabilities Accounts payable and accrued liabilities 707 908 Deferred contributions (Note 6) 49,110 44,067 Deferred contributions related to capital assets (Note 7) 100 118 49,917 45,093 Commitments and contingencies (Notes 9 and 10) Net assets - - 49,917 45,093 On behalf of the Board Director Director See accompanying notes to financial statements Page 2